两片式蘑菇状角膜移植术治疗外伤性角膜瘢痕的长期疗效
该单中心介入性病例系列纳入41只因穿透性角膜损伤导致全层外伤性角膜瘢痕、内皮功能尚可的眼,行两片式微角膜刀辅助蘑菇状角膜移植术(MK)。术后2年多数眼获得较好视力,排除影响视力的合并症后视力显著改善并长期稳定,内皮细胞丢失相对稳定,排斥和移植失败率低。
要点
- 两片式微角膜刀辅助MK可用于外伤性角膜瘢痕且内皮功能尚可的眼。
- 排除影响视力的合并症后,术后2年BSCVA显著改善并稳定至10年。
- 10年累积排斥风险和移植失败风险分别为8.5%和10%。
核心结论
- 两片式微角膜刀辅助MK治疗外伤性角膜瘢痕可实现良好的视力康复,内皮细胞丢失相对稳定,免疫排斥和移植失败率低。
研究设计与样本
- 单中心介入性病例系列,连续纳入41只因穿透性角膜损伤导致全层外伤性角膜瘢痕、内皮功能尚可的眼,行两片式微角膜刀辅助蘑菇状角膜移植术(MK)。
- 两片式蘑菇状移植物由直径9 mm的前层和直径6 mm的后层组成。
主要发现
- 41只眼中,术后2年38只眼(93%)达到Snellen视力≥20/100,36只眼(88%)达到≥20/60,29只眼(71%)达到≥20/40,13只眼(32%)达到≥20/25。
- 排除影响视力的合并症后,基线logMAR BSCVA(1.41 ± 0.73)在术后前2年逐年显著改善(P < 0.001),第2年达0.16 ± 0.13,此后至10年保持稳定(P = .626)。
- 5只眼因高度散光行伤口修整后,2只眼(5%)RA超过4.5屈光度。
- 内皮细胞丢失术后1年为35.1%,10年间年下降2.9%。
- 术后7只眼出现IOP升高,其中6只眼有既往青光眼。
关键数值与推荐
- 术后2年Snellen视力≥20/100、≥20/60、≥20/40、≥20/25的比例分别为93%、88%、71%、32%。
- 排除影响视力的合并症后,基线logMAR BSCVA为1.41 ± 0.73,第2年为0.16 ± 0.13(前2年逐年改善P < 0.001,此后至10年稳定P = .626)。
- 内皮细胞丢失术后1年为35.1%,10年间年下降2.9%。
- 10年累积移植排斥风险和移植失败风险分别为8.5%和10%。
临床怎么用
- 对于穿透性角膜损伤后全层角膜瘢痕且内皮功能尚可的眼,可考虑两片式微角膜刀辅助MK以改善视力。
- 术后需关注眼压升高,尤其是有青光眼病史者。
- 术后需长期监测内皮细胞密度、移植排斥和移植失败。
局限性
- 本研究为单中心介入性病例系列,非对照研究。
- 部分眼存在影响视力的合并症,视力分析时需排除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the outcomes of 2-piece microkeratome-assisted mushroom keratoplasty (MK) for eyes with full-thickness traumatic corneal scars and otherwise functional endothelium following corneal penetrating injury. DESIGN: This was an interventional case series. METHODS: In this single-center study, 41 consecutive eyes with traumatic corneal scars that underwent 2-piece microkeratome-assisted mushroom keratoplasty were evaluated. The 2-piece mushroom graft consisted of an anterior lamella 9 mm in diameter and a posterior lamella 6 mm in diameter. Outcome measures were best spectacle-corrected visual acuity (BSCVA), refractive astigmatism (RA), endothelial cell density, and postoperative complication rates. RESULTS: Of the 41 total cases, 38 eyes (93%) reached Snellen vision ≥20/100, 36 (88%) reached ≥20/60, 29 (71%) reached ≥20/40, and 13 (32%) reached ≥20/25 2 years following MK. Excluding eyes with vision-impairing comorbidities, baseline logMAR BSCVA (1.41 ± 0.73) significantly improved annually during the first 2 years (P < 0.001), reaching 0.16 ± 0.13 at year 2, which subsequently remained stable up to 10 years (P = .626). The RA exceeded 4.5 diopters in 2 cases (5%) after wound revision for high-degree astigmatism in 5 cases. Endothelial cell loss was 35.1% at 1 year, with an annual decline of 2.9% over 10 years. Elevation in IOP was observed postoperatively in 7 eyes, of which 6 had pre-existing glaucoma. The 10-year cumulative risk for graft rejection and failure was 8.5% and 10%, respectively. CONCLUSION: Two-piece microkeratome-assisted MK for traumatic corneal scars can allow excellent visual rehabilitation with relatively stable ECL and low rates of immunologic rejection and graft failure.
引用
- Yu AC, Spena R, Fusco F, et al. Long-Term Outcomes of Two-Piece Mushroom Keratoplasty for Traumatic Corneal Scars. Am J Ophthalmol. 2021. PMID: 34627739. doi:10.1016/j.ajo.2021.09.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。